Google partners with Mayo Clinic on radiotherapy AI October 30, 2020 -- Google Health is partnering with the Mayo Clinic to develop an artificial intelligence (AI) system that can support physicians, help reduce treatment planning time, and improve the efficiency of radiotherapy.
GE touts $40M savings with Command Center October 30, 2020 -- Tampa General Hospital has reported saving $40 million by reducing inefficiencies across its healthcare system since adopting GE Healthcare's Command Center Software last August.
Accuray's fiscal Q1 revenue declines October 30, 2020 -- Radiation oncology firm Accuray has released financial results for its first quarter of fiscal 2021 that show a drop in revenue from last year.
Race, ethnicity vary in radiation therapy trials October 29, 2020 -- Asian Americans are underrepresented in U.S. radiation therapy clinical trials relative to population size, while Black Americans are nearly on par, according to a study presented on October 27 at the American Society for Radiation Oncology annual meeting.
Radiation therapy access grows, but not in rural areas October 29, 2020 -- The number of radiation therapy facilities in the U.S. has grown by 17% in recent years, but they tend to be based in more populated areas, so some rural patients may still be missing out, according to a new study presented at the American Society for Radiation Oncology annual meeting.
Lantheus, Insightec to partner October 29, 2020 -- Lantheus Medical Imaging and MR-guided focused ultrasound (MRgFUS) developer Insightec have entered into an agreement under which Lantheus will provide Insightec with microbubbles to be used to evaluate treatment of glioblastoma and neurodegenerative conditions.
Breast care facility opens in Abu Dhabi October 29, 2020 -- Cleveland Clinic Abu Dhabi has opened a facility dedicated to breast health as an effort to bolster oncology care for patients in the region.
FDA clears DiA's cardiac ultrasound AI October 29, 2020 -- Echocardiography image analysis software developer DiA Imaging Analysis has received clearance from the U.S. Food and Drug Administration (FDA) for its LVivo Seamless cardiac ultrasound artificial intelligence (AI) software.